Navigation Links
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Date:4/29/2011

gulation of the biopharmaceutical industry and other important factors set forth more fully in our reports filed with the Securities and Exchange Commission, to which investors are referred for further information. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements, which speak only as of the date of publication of this press release. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that we may make. We do not have a policy of updating or revising forward-looking statements and, except as required by law, assume no obligation to update any forward-looking statements.

SVNT-GContact:Mary Coleman

Kelly Sullivan / Jennifer FriedmanSavient Pharmaceuticals, Inc.

Joele Frank, Wilkinson Brimmer Katcherinformation@savient.com

ksullivan@joelefrank.com / (732) 418-9300

jfriedman@joelefrank.com(212) 355-4449
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Calif. , June 30, 2015  Ardelyx, Inc. ... on cardio-renal, gastrointestinal and metabolic diseases, today announced that ... July 14, 2015, from 8:00 a.m.- 1:00 pm EDT ... The Ardelyx senior management team will present ... lead compound, tenapanor, which has completed Phase 2b clinical ...
(Date:6/30/2015)... 30, 2015  July 4 th is this weekend, ... the spirit and people behind it. To help honor our ... USA Medical Card, a leading provider ... programs that empower independence for our disabled military veterans, police, ... people afford their prescriptions. "Due to ...
(Date:6/30/2015)... WAYNE, Pa. , June 30, 2015 ... ("Egalet"), a fully integrated specialty pharmaceutical company ... pain treatments, today announced top-line results from ... study of Egalet-002, an abuse-deterrent, extended-release, oral ... for the management of pain severe enough ...
Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... Misonix, Inc. (Nasdaq: MSON ), a developer ... which worldwide is used for acute health conditions, today ... year ending June 30, 2010.  Michael A. McManus, Jr., ... VP and Chief Financial Officer, will host a conference ...
... YORK, Sept. 28 Reportlinker.com announces that a new ... Global In Vitro Diagnostics (IVD) Market Report: ... The global IVD market has been experiencing ... has been growing awareness about health and prevention of ...
Cached Medicine Technology:Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 2Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 3Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 4Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 5Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 6Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 7Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 8Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 9Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 2Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 3Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 4Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 5
(Date:6/30/2015)... ... June 30, 2015 , ... The American Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law ... Law Firm and Attorney Award respectively. As of July 1, 2015, the firm and ... attorney in Northern New Jersey. The award is a culmination of the hard work, ...
(Date:6/30/2015)... ... June 30, 2015 , ... The Blue Cross and Blue Shield of Minnesota ... the state. The projects improve community health by focusing on the social and economic ... are renewable for a second year in 2016 based on progress in 2015. , ...
(Date:6/30/2015)... Columbus, Ohio (PRWEB) , ... June 30, 2015 ... ... management services nationwide, is pleased to announce it’s own Debby Mann, CPC, RCC, ... Management Association (RBMA) Radiology Summit with the Special Recognition Award for her contribution ...
(Date:6/30/2015)... IL (PRWEB) , ... June 30, 2015 , ... The ... educate women on fertility preservation and deciding the right age to pursue egg freezing. ... until after the age of 35 — a 150 percent increase since the 1970s. ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association in California announced its ... San Diego. Speakers and clean air advocates included San Diego County Supervisor Ron Roberts, ... Hospital, and Daniel Sullivan, founder and president of Sullivan Solar Power. , For ...
Breaking Medicine News(10 mins):Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3
... able to predict which adults with mild cognitive impairment are ... results of a study published online and in the June ... is an intermediate stage between the decline in mental abilities ... associated with dementia, a group of brain disorders that includes ...
... of 10 adults think the U.S. health care system ... to a Commonwealth Fund survey released today. The concerns ... and growing costs. The survey also reveals strong support ... teams and information systems. The new survey ...
... the local tavern might be doing more than increasing ... suppressing social anxiety. New research from the University of ... the body,s natural responses to stress by inhibiting stress ... These hormones are located along the hypothalamic-pituitary-adrenal (HPA) axis, ...
... , TUESDAY, April 5 (HealthDay News) -- New research shows ... of Alzheimer,s disease, but it doesn,t serve as an early ... helpful because they reveal that signs of Alzheimer,s lurk in ... "What,s promising is that we can get such clear ...
... the April 6 issue of the Journal of the ... women who have had a hysterectomy because of longstanding evidence ... editorial is a response to a study in the same ... used in women with menopausal symptoms who have had a ...
... -- For people with hard-to-control blood pressure, a new ... surgically placed just below the collarbone, sends a four- ... is said to lower blood pressure through a process ... scheduled to present their findings Tuesday at the annual ...
Cached Medicine News:Health News:Using MRI, researchers may predict which adults will develop Alzheimer's 2Health News:New survey: 72 percent of Americans think health-care system needs major overhaul 2Health News:New survey: 72 percent of Americans think health-care system needs major overhaul 3Health News:Elevated levels of sodium blunt response to stress, study shows 2Health News:Blood Marker Suggests Severity of Alzheimer's Disease 2Health News:Blood Marker Suggests Severity of Alzheimer's Disease 3Health News:Caution for estrogen therapy after hysterectomy 2Health News:Caution for estrogen therapy after hysterectomy 3Health News:Implantable Device May Lower Tough-to-Treat Hypertension 2Health News:Implantable Device May Lower Tough-to-Treat Hypertension 3
... Stainless steel spiral reinforced. X-ray opaque . Low ... Flange: The flange can be adjusted along the ... cervical soft tissue. The lock ring is turned ... the shaft. Maximum Patient Comfort: The tube is ...
... Per-fit™ tubes are a dual ... of the disposable inner cannula ... provided in the procedural tray. ... tubes are available separately. Per-fit™ ...
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
Thermosensitivity of material allows tube to conform to patients anatomy for maximum patient comfort....
Medicine Products: